SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-552072
Filing Date
2016-04-22
Accepted
2016-04-22 16:23:09
Documents
4
Period of Report
2016-06-02
Effectiveness Date
2016-04-22

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE NOTICE AND PROXY STATEMENT d170618ddef14a.htm DEF 14A 852863
2 GRAPHIC g170618dsp045.jpg GRAPHIC 40649
3 GRAPHIC g170618g96b41.jpg GRAPHIC 31050
4 GRAPHIC g170618g96l35.jpg GRAPHIC 26498
  Complete submission text file 0001193125-16-552072.txt   989677
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: DEF 14A | Act: 34 | File No.: 001-32302 | Film No.: 161586958
SIC: 3841 Surgical & Medical Instruments & Apparatus